Barclays downgrades Synaptics to Equal-Weight, raises target to $135
Barclays analyst Tom O'Malley downgraded Synaptics from Overweight to Equal-Weight while raising the price target to $135 from $110.
*this image is generated using AI for illustrative purposes only.
Barclays analyst Tom O'Malley has downgraded Synaptics from Overweight to Equal-Weight. The rating change accompanies an increase in the price target to $135 from the previous $110.
The adjustment reflects a revised outlook on the stock's performance potential following recent market movements. The new price target suggests a specific valuation level that Barclays believes aligns more accurately with the company's current fundamentals.
Rating and Price Target Changes
The following table summarizes the revisions made by Barclays:
| Metric | Previous | New |
|---|---|---|
| Rating | Overweight | Equal-Weight |
| Price Target | $110 | $135 |
Synaptics is listed on the NASDAQ under the ticker symbol SYNA.
What specific market movements prompted Barclays to lower the rating while raising the price target?
How might this downgrade impact Synaptics' stock performance in the short term?
What are the key fundamentals Barclays used to justify the new $135 price target?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
